This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02132/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02132/identifier/chemspider/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02132/identifier/pdb/
n5http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02132/identifier/bindingdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02132/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02132/identifier/pubchem-substance/

Statements

Subject Item
n2:DB02132
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB02132 n10:DB02132
dcterms:title
[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid
adms:identifier
n9:5724 n11:46507491 n12:DB02132 n13:ZES n14:16496 n15:5522
n4:IUPAC-Name
n5:271B40C8-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B40CE-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B40CD-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B40CA-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B40CB-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B40CC-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B40C6-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B40C4-363D-11E5-9242-09173F13E4C5 n5:271B40C7-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B40C5-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B40D4-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B40D5-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B40CF-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B40D0-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B40D2-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B40D1-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B40D3-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B40DA-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B40DC-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B40DD-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B40D9-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B40D8-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B40DB-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B40C9-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B40D6-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B40D7-363D-11E5-9242-09173F13E4C5